中国临床药学新方向: 采用“形式遵循功能”方式, 提高医疗保健效果

doi:10.5246/jcps.2018.05.036

摘要/Abstract

摘要：

临床药学是现代药学实践中的重要发展。在中国, 卫计委对临床药师的认可是成功改变药师职能作用的重要一步, 使药师直接参与提高医疗效果。为使这种职能作用改变最优化, 我们建议实行“形式遵循功能”的方式。我们认为由3个部分组成的“形式”是非常可取的, 应精心协调建立: (1)正规教育/培训课程; (2)带领实践/研究临床改进的专业组织; (3)进行优质教育/培训和实践的认证机构。通过结合美国和其他国家的临床药学经验并采用这种“形式遵循功能”的方式, 可以预见中国临床药师的光明未来, 作为临床治疗团队的重要一员, 对医疗保健效果产生积极的影响。

关键词: 临床药学, 中国, 医疗保健

Abstract:

Clinical pharmacy is an important development in modern pharmacy practice. In China, the recent recognition of clinicalpharmacists by the Ministry of Health is an important step that can lead to a successful change in the functional role of the pharmacists to directly improve the health care outcomes. To optimize this role change, we propose that a “form follows function” structure be implemented. We believe that a “form” consisting of three components is highly desirable and should be established with careful coordination: (1) a formal education/training curriculum; (2) a professional organization to lead the clinical improvements in practice/research; and (3) an accrediting body for quality education/training and practice. By incorporating the clinical pharmacy experiences in USA and other countries as well as adopting this “form follows function” approach, we predict a bright future for the clinical pharmacists in China as valuable members of health care team to positively impact the health care outcomes.

Key words: Clinical pharmacy, China, Healthcare

中图分类号:

R951

Supporting:

陈孝, 高翔, 陈杰, Sheryl L Chow, Moses S.S. Chow. 中国临床药学新方向: 采用“形式遵循功能”方式, 提高医疗保健效果[J]. 中国药学(英文版), 2018, 27(5): 352-360.

Xiao Chen, Xiang Gao, Jie Chen, Sheryl L Chow, Moses S.S. Chow. New direction for clinical pharmacy in China: adopting a “form follows function” approach to improve future healthcare outcomes[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 352-360.

参考文献

[1] ACCP. The definition of clinical pharmacy. Pharmacotherapy. 2008, 28, 816-817.

[2] Day, R.L.; Goyan, J.E.; Herfindal, E.T.; Sorby, D.L. The orgins of the clinical pharmacy program at the University of California, San Francisco. DICP, Ann. Pharmacotheraphy. 1991, 25, 308-314.

[3] Summary of petition requesting recognition of clinical pharmacy as a specialty. Committee on clinical pharmay as a specialty. Am. J. Hosp. Pharm. 1986, 43, 1267-1277.

[4] Chrischilles, E.A.; Helling, D.K.; Rowland, C.R. Clinical pharmacy service in family practice: cost-benefit analysis. II. Referrals, appointment compliance, and costs. Drug Intell. Clin. Pharm. 1984, 18, 436-441.

[5] Bond, C.A.; Raehl, C.L. Clinical pharmacy services, pharmacy staffing, and hostpital mortality rates. Pharmacotherapy. 2007, 27, 481-493.

[6] Carter, B. Evolution of clinical pharmacy in the USA and future directions for patient care. Drugs Aging. 2016, 33, 169-177.

[7] Lee, J.K.; Grace, K.A.; Taylor, A.J. Effect of a pharmcy care program on medication adherence and persistence, blood, pressure, and low-density lipoprotein cholesterol: a randomized controled trial. J. Am. Med. Assoc. 2006, 296, 2563-2571.

[8] Schumock, G.T.; Butler, M.G.; Meek, P.D.; Vermeulen, L.C.; Arondekar, B.V.; Bauman, J.L. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003, 23, 113-132.

[9] Frankel, G.; Louizos, C.; Austin, Z. Canadian Educational Approaches for the Advancement of Pharmacy Practice. Am. J. Pharm. Educ. 2014, 78, 143.

[10] American College of Clinical Pharmacy. Practice and research networks. American College of Clinical Pharmacy. Washington, DC. https://www.accp.com/about/prns.aspx

[11] Nunes-da-Cunha, I.; Arguello, B.; Martinez Martinez, F.; Fernandez-Llimos, F. A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe. Am. J. Pharm. Educ. 2016, 80, 1-12.

[12] World Economic Forum, 2015. Deep shift: 21 ways software will transform globabl society. Global Agenda Council on the Future of Software & Society. http://www3.weforum.org/docs/WEF_GAC15_Deep_Shift_ Software_Transform_Society.pdf

[13] Lofgren, B., 2015. Could a robot do a pharmacists job? Pharmacy Times: Practical Information For Today’s Pharmacists. http://www.pharmacytimes.com/contributor/ beth-lofgren-pharmd-bcps/2015/09/could-a-robot-do-a-pharmacists-job

[14] Giles, S., 2017. Essential skills to keep you job in the era of artificial intelligence. Forbes. https://www.forbes.com/ sites/forbescoachescouncil/2017/04/25/essential-skills-to-keep-your-job-in-the-era-of-artificial-intelligence/#26ddb9717ae1

[15] Lofgren, B. Could a robot do your job? http://www.theblondepharmacist.com/blog//could-a-robot-do-your-job

[16] Medical Futurist. The bright future of pharmacies. http://medicalfuturist.com/the-bright-future-of-pharmacies/

[17] Street, C.W., 2016. Your Pharmacists will soon be a robot. http://www.breitbart.com/california/2016/05/02/pharmacist-will-soon-app-robot/

[18] Hu, M.; Yee, G.; Zhou, N.T.; Yang, N.; Jiang, X.H.; Klepser D. Development and current status of clinical pharmacy education in China. Am. J. Pharm. Educ. 2014, 78, 157.

[19] MiHIA, 2016. What is the quadruple aim? Michigan Health Improvement Alliance, Inc. https://www.mihia.org/ index.php/quad-aim/what-is-the-quad-aim

[20] Zhou, M.; Wang, H.; Zhu, J.; Chen, W.; Wang, L.; Liu, S.; Li, Y.; Wang, L.; Liu, Y.; Yin, P.; Liu, J.; Yu, S.; Tan, F.; Barber, R.M.; Coates, M.M.; Dicker, D.; Fraser, M.; Gonzalez-Medina, D.; Hamavid, H.; Hao, Y.; Hu, G.; Jiang, G.; Kan, H.; Lopez, A.D.; Phillips, M.R.; She, J.; Vos, T.; Wan, X.; Xu, G.; Yan L.L.; Yu, C.; Zhao, Y.; Zheng, Y.; Zou, X.; Naghavi, M.; Wang, Y.; Murray, C.J.; Yang, G.; Liang, X. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease. Lancet. 2016, 387, 251-272.

[21] Al Hamarneh, Y.N.; Hemmelgarn, B.; Curtis, C.; Balint, C.; Jones, C.A.; Tsuyuki, R.T. Community pharmacists targeted screening for chronic kidney disease. Can. Pharm. J. (Ott). 2016, 149, 13-17.

[22] Charrois, T.L.; Zolezzi, M.; Koshman, S.L.; Pearson, G.; Makowsky, M.; Durec, T.; Tsuyuki, R.T. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012, 32, 222-233.

[23] Houle, S.K.D.; Charrois, T.L.; McAlister, F.A.; Kolber, M.R.; Rosenthal, M.M.; Lewanczuk, R.; Campbell, N.R.; Tsuyuki, R.T. Pay-for-performance remuneration for pharmacists prescribers’ management of hypertension: a substudy of the RxACTION trial. Can. Pharm. J. (Ott). 2016, 149, 345-351.

[24] Tsuyuki, R.T.; Al Hamarneh, Y.N.; Jones, C.A.; Hemmelgarn, B.R. The effectiveness of pharmacists interventions on cardiovascular risk: the multicenter randomized controlled rxEACH trial. J. Am. Coll. Cardiol. 2016, 67, 2846-2854.

[25] Tsuyuki, R.T.; Rosenthal, M.; Pearson, G.J. A randomized trial of community-based approach to dyslipidemia management: pharmacists perscribing to achieve cholestrol targets (RxACT study). Can. Pharm. J. (Ott). 2016, 149, 283-292.

[26] Carter, B.L.; Coffey, C.S.; Ardery, G.; Uribe, L.; Ecklund, D.; James, P.; Egan, B.; Vander Weg, M.; Chrischilles, E.; Vaughn, T. A cluster randomized trial of physician/pharmacist collaborative model to improve blood pressure control. Circ. Cardiovasc. Qual. Outcomes. 2015, 8, 235-243.

[27] Jacob, V.; Chattopadhyay, S.K.; Thota, A.B.; Proia, K.K.; Njie, G.; Hopkins, D.P.; Finnie R.K.C.; Pronk, N.P.; Kottke, T.E. Economics of team-based care in controlling blood pressure: a community guide systematic review. Am. J. Prev. Med. 2015, 49, 772-783.

[28] Maxwell Anderegg, M.D.; Gums, T.H.; Uribe, L.; Coffey, C.S.; James, P.A.; Carter, B.L. Physician-pharmacists collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension. 2016, 68, 1314-1320.

[29] Ho, S.S.; Kember, D.; Lau, C.B.; Au Yeung, M.Y.; Leung, D.Y.; Chow, M.S.S. An outcomes-based approach to curriculum development in pharmacy. Am. J. Pharm. Edu. 2009, 73, 1-9.

[30] Medina, M.S.; Plaza, C.M.; Stowe, C.D.; Robinson, E.T.; DeLander, G.; Beck, D.E.; Melchert, R.B.; Supernaw, R.B.; Roche, V.F.; Gleason, B.L.; Strong, M.N.; Bain, A.; Meyer, G.E.; Dong, B.J.; Rochon, J.; Johnston, P. Center for the Advancement of Pharmacy Education 2013 educational outcomes. Am. J. Pharm. Edu. 2013, 77, 162.

[31] Accreditation Council for Pharmacy Education. PharmD program accreditation. Accreditation Council for Pharmacy Education, Chicago, IL. https://www.acpe.edu/

[32] Curriculum SIG Writing Group. A curriculum committee toolkit for addressing the 2013 CAPE outcomes. American Association of Colleges of Pharmacy. https://www.aacp.org/ sites/default/files/201710/CurriculumSIGCAPEPaper FinalNov2014.pdf

[33] Fulford, M.J.; Souza, J.M. CAPE-A.B.L.E. Center for the Advancement of Pharmacy Education: an assessment blueprint for learning experiences. American Association of Colleges of Pharmacy. https://www.aacp.org/sites/default/files/2017-10/Assessment%20CAPE%20Paper-%20Final%2011.pdf

[34] American College of Clinical Pharmacy. ACCP PRN Histories. American College of Clinical Pharmacy. Lenexa, KS. https://www.accp.com/prns/history.aspx

[35] ACPE, 2015. Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree. Accreditation Council for Pharmacy Education. Chicago, Illinois. https://pharmacy.isu.edu/appe/docs/ACPE_Standards_2016.pdf
[36] Board of Pharmacy Specialties, 2018. My BPS. American Pharmacists Association. NW Washington, DC. https://www.bpsweb.org/